Archive for Charles Delvalle

Charles DelvalleCharles Delvalle is a self-taught market-timing professional and value analyst who uses a combination of technical indicators and fundamental research to achieve consistent gains on stocks, commodities and options. Charles is also a staunch contrarian and takes pride in finding undervalued sectors and discovering great companies on the cheap. He questions government reports and the status quo. In addition to swing trading options, Charles is also Co-Editor of the monthly advisory service - INCOME.

The Silver Ship has Left the Dock

Over the past few months we’ve been telling you about how silver enters a seasonal push around mid-summer and goes on to move higher until the end of the year.

Obama’s Nasty Effect on Pharmaceutical Companies

Some of the most solid opportunities in the stock market are those that happen because of politics. Let’s face it, the government controls billions of dollars and could make or break industries. The effect an Obama presidency could have on Pharmaceutical companies is one you should be well aware of.

6 Rules Every Investor Should Follow

It’s been another troubled week for the US markets. After a brief rally stocks tumbled. The Standard & Poor’s 500 Index had the worst weekly losses in four years. Oil hit new records. How can you profit under such volatile conditions? Charles Delvalle says there are six rules to follow for successful investing.

When Oil Goes Down Stocks Will Go Up

It may be a simple observation, but we think it may be spot on. Charles Delvalle says that the price of oil is depressing stocks. It’s likely well see a rally in stocks if oil prices come down…

Ride or Slide: United Technologies (UTX)

Charles Devalle says: “Just when you thought things were at their worst, now investors are worrying about the election. Obama wants to pull troops from Iraq, which would mean less defense spending. McCain isn’t in a hurry to pull troops out, which means a continuation of defense spending.”

When Is It Time to Short a Stock?

Editor’s note: When is it time to short a stock, asks Charles Delvalle. Check the dividends – if they’ve cut them down or cut them out, then get shorting…

Pfizer: Time to Invest?

Editor’s note:  Is it time to consider Pfizer as a serious investment? Let it slide lower first, says Charles Delvalle.

Fed Decision Means Inflation Here to Stay

Editor’s note: The Federal Reserve is living in dreamland if it thinks US inflation’s going to come down this year, says Charles Delvalle in Investor’s Daily Edge. The price of imports will see to that. Bernanke should follow Europe’s lead and think about raising interest rates.

Fitch Downgrades GM and Chrysler

With US gas prices over $4 a gallon, Investor’s Daily Edge’s Charles Delvalle isn’t surprised the auto companies are hurting. Half of their sales still come from pick-ups and SUVs…

The outlook for US auto companies certainly isn’t looking good. Yesterday, Fitch Ratings downgraded GM and Chrysler’s investment ratings to from a B to a B-.

Both companies now have a negative outlook, meaning they could be downgraded further. Ford Motor Co’s rating is being reviewed.

Ride or Slide: Enzo BioChem (ENZ)

I recently got a letter from a reader wondering what I thought about Enzo BioChem (ENZ). ENZ is a life sciences and biotechnology company that provides diagnostic services to the medical community. Among other things, they are involved in coming up with genetic cures to illnesses like HIV.

Receive These Valuable Investing Strategy Resources to Your Inbox Courtesy of Contrarian Profits

    Subscribe
We respect your privacy.
Choose any of the FREE subscription services below that you'd like to receive, enter your email address, and click 'subscribe'.
The Daily Reckoning



Select Edition:
DailyWealth

Penny Sleuth

Money Morning

Investor's Daily Edge

Money Morning UK

Investment U

Whiskey and Gunpowder

Taipan Daily

The Growth Stock Wire

Offshore A-Letter

Today's Financial News

International Living

The Smart Profits Report

Spiritual Wealth